β2-glycoprotein I and annexin A5 phospholipid interactions: Artificial and cell membranes

Autoimmunity Reviews

Volumn 9, Issue 1, 2009, Pages 5-10

  Frank, Mojca ^a   Sodin Šemrl, Snežna ^a   Irman, Špela ^a   Božič, Borut ^a,b   Rozman, Blaž ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

2 glycoprotein I; 2 glycoprotein I receptors; Annexin A5; Antiphospholipid syndrome; Phospholipid interactions

Indexed keywords

BETA2 GLYCOPROTEIN 1; LIPOCORTIN 2; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE RECEPTOR; PHOSPHOLIPID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; ANTICOAGULANT AGENT;

ANTIGENICITY; ANTIPHOSPHOLIPID SYNDROME; ARTIFICIAL MEMBRANE; CELL ADHESION; CELL MEMBRANE; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; CRYSTALLIZATION; DIMERIZATION; ELECTRICITY; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; NONHUMAN; OLIGOMERIZATION; PREGNANCY COMPLICATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; THROMBOSIS; ALLOSTERISM; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; ANNEXIN A5; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; FEMALE; HUMANS; MEMBRANES, ARTIFICIAL; PREGNANCY; PREGNANCY COMPLICATIONS; SIGNAL TRANSDUCTION;

EID: 69649095448     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.025     Document Type: Review

References (40)

1. Lutters B.C., Derksen R.H., Tekelenburg W.L., Lenting P.J., Arnout J., and de Groot P.G. Dimers of β2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J Biol Chem 278 (2003) 33831-33838
2. Rand J.H., Wu X.X., Quinn A.S., and Taatjes D.J. Resistance to annexin A5 anticoaglant activity: a trombogenic mechanism for the antiphospholipid syndrome. Lupus 17 (2008) 922-930
3. Božič B., Irman Š., Gašperšič N., Kveder T., and Rozman B. Antibodies against annexin A5: detection pitfalls and clinical associations. Autoimmunity 38 (2005) 425-430
4. Sodin-Šemrl S., Frank M., Ambrožič A., Pavlič J., Šuštar V., Čučnik S., et al. Interactions of phospholipid binding proteins with negatively charged membranes: β2-glycoprotein I as a model mechanism. In: Leitmannova Liu A. (Ed). Advances in planar lipid bilayers liposomes (2008), Elsevier, Amsterdam 243-273
5. Gamsjaeger R., Johs A., Gries A., Gruber H.J., Romanin C., Prassl R., et al. Membrane binding of β2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study. Biochem J 389 (2005) 665-673
6. Hamdan R., Maiti S.N., and Schroit A.J. Interaction of β2-glycoprotein 1 with phosphatidylserine-containing membranes: ligand-dependent conformational alterations initiate bivalent binding. Biochemistry 46 (2007) 10612-10620
7. Bevers E.M., Zwaal R.F., and Willems G.M. The effect of phospholipids on the formation of immune complexes between autoantibodies and β2-glycoprotein I or prothrombin. Clin Immunol 112 (2004) 150-160
8. Gushiken F.C., Le A., Arnett F.C., and Thiagarajan P. Polymorphisms of β2-glycoprotein I: phospholipid binding and multimeric structure. Thromb Res 108 (2002) 175-180
9. Bohlin M.E., Kogutowska E., Blomberg L.G., and Heegaard N.H. Capillary electrophoresis-based analysis of phospholipid and glycosaminoglycan binding by human β2-glycoprotein I. J Chromatogr A 1059 (2004) 215-222
10. Merten M., Motamedy S., Ramamurthy S., Arnett F.C., and Thiagarajan P. Sulfatides: targets for antiphospholipid antibodies. Circulation 108 (2003) 2082-2087
11. Dupuy D'Angeac A., Stefas I., Graafland H., De Lamotte F., Rucheton M., Palais C., et al. Biotinylation of glycan chains in β2-glycoprotein I induces dimerization of the molecule and its detection by the human avtoimmune anticardiolipin antibody EY2C9. Biochem J 393 (2006) 117-127
12. Hagihara Y., Hong D.P., Hoshino M., Enjyoji K., Kato H., and Goto Y. Aggregation of β2-glycoprotein by sodium lauryl sulphate and lysophospholipids. Biochemistry 41 (2002) 1020-1026
13. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., Hathcock J.J., and Taatjes D.J. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers. Blood 112 (2008) 1687-1695
14. Čučnik S., Kveder T., Rozman B., and Božič B. Binding of high avidity anti-β2-glycoprotein I antibodies. Rheumatology 43 (2004) 1353-1356
15. Hayashi A., Hayashi A., Matsuura E., Suzuki K., Koike T., Hashimoto E., et al. Self-interaction of soluble and surface-bound β2-glycoprotein I and its enhancement by lupus anticoagulants. FEBS Lett 582 (2008) 3308-3312
16. Pennings M.T., van Lummel M., Derksen R.H., Urbanus R.T., Romijn R.A., Lenting P.J., et al. Interaction of β2-glycoprotein I with members of the low density lipoprotein receptor family. J Thromb Haemost 4 (2006) 1680-1690
17. Shi T., Giannakopoulos B., Yan X., Yu P., Berndt M.C., Andrews R.K., et al. Anti-β2-glycoprotein I antibodies in complex with β2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum 54 (2006) 2558-2567
18. Giannakopoulos B., Passam F., Rahgozar S., and Krilis S.A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 (2007) 422-430
19. Pennings M.T., Derksen R.H., van Lummel M., Adelmeijer J., VanHoorelbeke K., Urbanus R.T., et al. Platelet adhesion to dimeric β2-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ib alpha and apolipoprotein E receptor 2′. J Thromb Haemost 5 (2007) 369-377
20. Urbanus R.T., Pennings M.T., Derksen R.H., and de Groot P.G. Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'. J Thromb Haemost 6 (2008) 1405-1412
21. Ma K., Simantov R., Zhang J.C., Silverstein R., Hajjar K.A., and McCrae K.R. High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 275 (2000) 15541-15548
22. Meroni P.L., Raschi E., Testoni C., Parisio A., and Borghi M.O. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 3 (2004) 510-515
23. Sorice M., Longo A., Capozzi A., Garofalo T., Misasi R., Alessandri C., et al. Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 56 (2007) 2687-2697
24. Raschi E., Borghi M.O., Grossi C., Broggini V., Pierangeli S., and Meroni P.L. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 17 (2008) 937-942
25. Satta N., Dunoyer-Geindre S., Reber G., Fish R.J., Boehlen F., Kruithof E.K., et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109 (2007) 1507-1514
26. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
27. van Genderen H.O., Kenis H., Hofstra L., Narula J., and Reutelingsperger C.P. Extracellular annexin A5: Functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783 (2008) 953-963
28. Jeppesen B., Smith C., Gibson D.F., and Tait J.F. Entropic and enthalpic contributions to annexin V-membrane binding. A comprehensive quantitative model. J Biol Chem 283 (2008) 6126-6135
29. Andree H.A., Stuart M.C., Hermens W.T., Reutelingsperger C.P., Hemker H.C., Frederik P.M., et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267 (1992) 17907-17912
30. Gašperšič N., Ambrožič A., Božič B., Majhenc J., Svetina S., and Rozman B. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-β2-glycoprotein I and anti-annexin A5 antibodies. Rheumatology 46 (2007) 81-86
31. Oling F., Sopkova-de Oliveira Santos J., Govorukhina N., Mazeres-Dubut C., Bergsma-Schutter W., Oostergetel G., et al. Structure of membrane bound annexin A5 trimers: a hybrid cryo-EM-X-ray crystallography study. J Mol Biol 304 (2000) 561-573
32. Mo Y., Campos B., Mealy T.R., Commodore L., Head J.F., Dedman J.R., et al. Interfacial basic cluster in annexin V couples phospholipid binding and trimer formation on membrane surfaces. J Biol Chem 278 (2003) 2437-2443
33. Richter R.P., Lai Kee Him J., Tessier B., Tessier C., and Brisson A.R. On the kinetics of adsorption and two-dimensional self-assembly of annexin A5 on the supported lipid bilayers. Biophys J 89 (2005) 3372-3385
34. Irman Š., Škarabot M., Muševič I., Rozman B., and Božič B. In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy. Autoimmunity 42 (2009) 414-423
35. Cederholm A., Svenugsson E., Jensen-Urstad K., Trollmo C., Ulfgren A.K., Swedenborg J., et al. Decreased binding of annexin A5 to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 25 (2005) 198-203
36. Sodin-Šemrl S., and Rozman B. β2-glycoprotein I and its clinical significance: from gene sequence to protein levels. Autoimmun Rev 6 (2007) 547-552
37. Ambrožič A., Čučnik S., Tomšič N., Urbanija J., Lokar M., Babnik B., et al. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with β2-glycoprotein-I and anti-β2-glycoprotein-I antibodies. Autoimmun Rev 6 (2006) 10-15
38. Frank M., Manček-Keber M., Kržan M., Sodin-Šemrl S., Jerala R., Iglič A., et al. Prevention of microvesiculation by adhesion of buds to the mother cell membrane-a possible anticoagulant effect of healthy donor plasma. Autoimmun Rev 7 (2008) 240-245
39. Hurst J., and von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 7 (2008) 204-208
40. Shoenfeld Y., Meroni P.L., and Cervera R. Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 67 (2008) 438-442